Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The end stage renal disease program

D A Goodkin

    The New England Journal of Medicine
    |July 8, 1993
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The dialysis outcomes and practice patterns study (DOPPS): how can we improve the care of hemodialysis patients?

    Seminars in dialysis·2001
    Same author

    A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism.

    Kidney international·2000
    Same author

    The Normal Haematocrit Trial in dialysis patients with cardiac disease.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1999
    Same author

    Hematocrit stability following intravenous versus subcutaneous administration of epoetin alfa to dialysis patients: a post hoc analysis.

    Clinical nephrology·1999
    Same author

    The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.

    The New England journal of medicine·1998
    Same author

    Acute oliguria.

    The New England journal of medicine·1998